236 related articles for article (PubMed ID: 16100994)
1. [Hyperammonemia secondary to the use of valproic acid: case report].
Turcato Mde F; Fernandes RM; Wichert-Ana L; Funayama CA
Arq Neuropsiquiatr; 2005 Jun; 63(2A):364-6. PubMed ID: 16100994
[TBL] [Abstract][Full Text] [Related]
2. Valproic acid-induced hyperammonemia: a case report.
McCall M; Bourgeois JA
J Clin Psychopharmacol; 2004 Oct; 24(5):521-6. PubMed ID: 15349008
[TBL] [Abstract][Full Text] [Related]
3. Valproate-induced hyperammonemic encephalopathy.
Verrotti A; Trotta D; Morgese G; Chiarelli F
Metab Brain Dis; 2002 Dec; 17(4):367-73. PubMed ID: 12602513
[TBL] [Abstract][Full Text] [Related]
4. Valproate-induced Hyperammonemic Encephalopathy Presenting as Catatonia.
Pérez-Esparza R; Oñate-Cadena N; Ramírez-Bermúdez J; Espínola-Nadurille M
Neurologist; 2018 Mar; 23(2):51-52. PubMed ID: 29494435
[TBL] [Abstract][Full Text] [Related]
5. Valproic acid-induced hyperammonemia and thrombocytopenia in an elderly woman.
Mallet L; Babin S; Morais JA
Ann Pharmacother; 2004 Oct; 38(10):1643-7. PubMed ID: 15316109
[TBL] [Abstract][Full Text] [Related]
6. Valproate-induced hyperammonemia - uncovering an underlying inherited metabolic disorder: a case report.
Mehta S; Tayabali S; Lachmann R
J Med Case Rep; 2018 May; 12(1):134. PubMed ID: 29769109
[TBL] [Abstract][Full Text] [Related]
7. Risk factors of hyperammonemia in patients with epilepsy under valproic acid therapy.
Tseng YL; Huang CR; Lin CH; Lu YT; Lu CH; Chen NC; Chang CC; Chang WN; Chuang YC
Medicine (Baltimore); 2014 Sep; 93(11):e66. PubMed ID: 25192484
[TBL] [Abstract][Full Text] [Related]
8. Cognitive side effects of valproic acid-induced hyperammonemia in children with epilepsy.
Nicolai J; Aldenkamp AP; Huizenga JR; Teune LK; Brouwer OF
J Clin Psychopharmacol; 2007 Apr; 27(2):221-4. PubMed ID: 17414255
[No Abstract] [Full Text] [Related]
9. [Valproic acid-induced hyperammonemic encephalopathy in a patient receiving valproic acid monotherapy].
Yamada H; Shishido T; Mukai T; Araki M; Naka H; Tokinobu H
Rinsho Shinkeigaku; 2019 May; 59(5):258-263. PubMed ID: 31061301
[TBL] [Abstract][Full Text] [Related]
10. Valproate induced hyperammonemic encephalopathy successfully treated with levocarnitine.
Rigamonti A; Lauria G; Grimod G; Bianchi G; Salmaggi A
J Clin Neurosci; 2014 Apr; 21(4):690-1. PubMed ID: 24119342
[TBL] [Abstract][Full Text] [Related]
11. A case of hyperammonaemic encephalopathy due to valproic acid.
Prins MC; van Meijel JJ
Neth J Med; 2011 Sep; 69(9):389-91. PubMed ID: 21978982
[TBL] [Abstract][Full Text] [Related]
12. Risk factors of hyperammonemia in epilepsy patients with valproic acid therapy.
Kwack DW; Kim DW
Clin Neurol Neurosurg; 2023 Oct; 233():107962. PubMed ID: 37717359
[TBL] [Abstract][Full Text] [Related]
13. Lacosamide-induced valproic acid toxicity.
Jones GL; Popli GS; Silvia MT
Pediatr Neurol; 2013 Apr; 48(4):308-10. PubMed ID: 23498565
[TBL] [Abstract][Full Text] [Related]
14. Influence of glutamine synthetase gene polymorphisms on the development of hyperammonemia during valproic acid-based therapy.
Inoue K; Takahashi T; Yamamoto Y; Suzuki E; Takahashi Y; Imai K; Inoue Y; Hirai K; Tsuji D; Itoh K
Seizure; 2015 Dec; 33():76-80. PubMed ID: 26599579
[TBL] [Abstract][Full Text] [Related]
15. 4217C>A polymorphism in carbamoyl-phosphate synthase 1 gene may not associate with hyperammonemia development during valproic acid-based therapy.
Inoue K; Suzuki E; Takahashi T; Yamamoto Y; Yazawa R; Takahashi Y; Imai K; Miyakawa K; Inoue Y; Tsuji D; Hayashi H; Itoh K
Epilepsy Res; 2014 Aug; 108(6):1046-51. PubMed ID: 24888247
[TBL] [Abstract][Full Text] [Related]
16. [A case of valproate-associated hyperammonemia with chronic hepatitis C].
Fukushima M; Kotoh K; Enjoji M; Nakamuta M; Nawata H; Aishima S
Nihon Shokakibyo Gakkai Zasshi; 2005 Jan; 102(1):42-7. PubMed ID: 15682815
[No Abstract] [Full Text] [Related]
17. Hyperammonemia and coma without hepatic dysfunction induced by valproate therapy.
Barrueto F; Hack JB
Acad Emerg Med; 2001 Oct; 8(10):999-1001. PubMed ID: 11581089
[TBL] [Abstract][Full Text] [Related]
18. Valproate-induced hyperammonemic encephalopathy: a case report and brief review of the literature.
Sunkavalli KK; Iqbal FM; Singh B; Koneru J
Am J Ther; 2013; 20(5):569-71. PubMed ID: 21248614
[TBL] [Abstract][Full Text] [Related]
19. [Valproate-induced hyperammonemic encephalopathy].
Granel B; Gavaret M; Le Baut X; Sautereau N; Rodriguez D; Rossi P; Bagnères D; Demoux AL; Francès Y
Rev Med Interne; 2011 Jun; 32(6):e72-5. PubMed ID: 20633966
[TBL] [Abstract][Full Text] [Related]
20. Valproate-induced hyperammonemic encephalopathy and normal liver functions: possible synergism with topiramate.
Deutsch SI; Burket JA; Rosse RB
Clin Neuropharmacol; 2009; 32(6):350-2. PubMed ID: 19952878
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
